miR-490-3p Suppresses EMT of SW1990 Pancreatic Cancer Cells

Jing-hui LI; Ming ZHU; Hai QU; Qiu-yu LI; Yu-juan WU; He-ying YANG; Yu-zhu WANG; Yan-ping LI

doi:10.12259/j.issn.2095-610X.S20210305

Volume 42 Issue 3

Apr. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2021 > 42(3): 10-17

Jing-hui LI, Ming ZHU, Hai QU, Qiu-yu LI, Yu-juan WU, He-ying YANG, Yu-zhu WANG, Yan-ping LI. miR-490-3p Suppresses EMT of SW1990 Pancreatic Cancer Cells[J]. Journal of Kunming Medical University, 2021, 42(3): 10-17. doi: 10.12259/j.issn.2095-610X.S20210305

Citation:

Jing-hui LI, Ming ZHU, Hai QU, Qiu-yu LI, Yu-juan WU, He-ying YANG, Yu-zhu WANG, Yan-ping LI. miR-490-3p Suppresses EMT of SW1990 Pancreatic Cancer Cells[J]. Journal of Kunming Medical University, 2021, 42(3): 10-17. doi: 10.12259/j.issn.2095-610X.S20210305

Citation:

PDF( 1103 KB)

miR-490-3p Suppresses EMT of SW1990 Pancreatic Cancer Cells

doi: 10.12259/j.issn.2095-610X.S20210305

1.
Dept. of Critical Care Medicine
2.
Dept. of Neurology，Yan’an Hospital of Kunming，Kunming Yunnan 650051，China

Received Date: 2020-12-15
Publish Date: 2021-04-09

Abstract

Abstract

Objective To elucidate the role of miR-490-3p in regulating HMGA2 expression and affecting epithelial-mesenchymal transition （EMT） of SW1990 cells. Methods miR-490-3p expression was measured in HPDE and SW1990 cell lines by Real-time PCR. SW1990 cell lines were cultured in vitro and divided into four groups, including inhibitor-Negative control （inhibitor-NC）, miR-490-3p inhibitor, mimic- Negative control （mimic-NC） and miR-490-3p mimic group, and the transfection efficiency was verified by RT-qPCR. After 48 h of transfection, CCK8 assay, wound healing assay, Transwell invasion assay andflow cytometric were used to detect the effects of malignant biological characteristics such as proliferation, migration, invasion and apoptosis of SW1990 cell linerespectively. Western blot was used to detect the expression of E-cadherin and N-cadherin. Meanwhile, database predicted the target genes of miR-490-3p, and dual luciferase assay confirmed the targeted relationship between miR-490-3p and HMGA2, western blot was used to detect the expression of HMGA2. Results 1） The expression of miR-490-3p was downregulated in SW1990 cells （P = 0.215）. 2） Overexpression of miR-490-3p significantly inhibited the proliferation （P < 0.0001）, migration （P < 0.0001） and invasion （P < 0.0001） of SW1990 cell line and prompted apoptosis （P < 0.0001）; In contrast, downregulation of miR-490-3p significantly promoted the proliferation （P < 0.0001）, migration （P < 0.0001） and invasion （P < 0.0001） of SW1990 cell line and inhibited apoptosis （P < 0.0001）. 3） Upregulation of miR-490-3p significantly decreased the expression of N-cadherin （P < 0.0001） and increased E-cadherin （P < 0.0001） expression in SW1990 cell line. In contrast, downregulation of miR-490-3p significantly upregulated （P < 0.0001） the expression of N-cadherin, decreased E-cadherin （P < 0.0001） expression. 4） HMGA2 was a target gene of miR-490-3p. Conclusion These findings indicate that miR-490-3p acts as a tumor suppressor during the process of EMT through targeting HMGA2, suggesting miR-490-3p is a potential new diagnostic and therapeutic target for the treatment of pancreatic cancer.
- Pancreatic cancer,
- EMT,
- miR-490-3p,
- HMGA2

FullText(HTML)

References(28)

References

[1]	Torre L A,Bray F,Siegel R L,et al. Global cancer statistics,2012[J]. CA:a Cancer Journal for Clinicians,2015,65(2):87-108. doi: 10.3322/caac.21262
[2]	Ansari D,Tingstedt B,Andersson B,et al. Pancreatic cancer:Yesterday,today and tomorrow[J]. Future Oncology (London,England),2016,12(16):1929-1946. doi: 10.2217/fon-2016-0010
[3]	许伟先,何志伟,喻超,等. microRNA-125b对胰腺癌侵袭转移的影响及其机制[J]. 贵阳医学院学报,2019,44(8):881-885.
[4]	Khan S,Anasrullah,Kumar D,et al. Targeting microRNAs in pancreatic cancer:microplayers in the big game[J]. Cancer Research,2013,73(22):6541-6547. doi: 10.1158/0008-5472.CAN-13-1288
[5]	Aiello N M,Brabletz T,Kang Y,et al. Upholding a role for EMT in pancreatic cancer metastasis[J]. Nature,2017,547(7661):E7-E8. doi: 10.1038/nature22963
[6]	Beuran M,Negoi I,Paun S,et al. The epithelial to mesenchymal transition in pancreatic cancer:A systematic review[J]. Pancreatology:Official Journal of the International Association of Pancreatology (IAP),2015,15(3):217-225. doi: 10.1016/j.pan.2015.02.011
[7]	Gaianigo N,Melisi D,Carbone C. EMT and treatment resistance in pancreatic cancer[J]. Cancers,2017,9(9):122-138.
[8]	Zhou P,Li B,Liu F,et al. The epithelial to mesenchymal transition (EMT) and cancer stem cells:implication for treatment resistance in pancreatic cancer[J]. Molecular Cancer,2017,16(1):52-63. doi: 10.1186/s12943-017-0624-9
[9]	王甫珏,李君君,谢海涛,等. 地西他滨对 K562 细胞增殖和 TFPI-2 基因表达的影响[J]. 中华血液学杂志,2017,38(4):340-343. doi: 10.3760/cma.j.issn.0253-2727.2017.04.016
[10]	Moore A,Donahue T. Pancreatic cancer[J]. Jama,2019,322(14):1426-1426. doi: 10.1001/jama.2019.14699
[11]	Beger H G, Birk D. Pancreatic cancer staging systems and their clinical impact[M]. Hoboken, New Jersey, USA: John Wiley & Sons, Ltd, 2009: 25-158.
[12]	Xu B,Liu J,Xiang X,et al. Expression of miRNA-143 in pancreatic cancer and its clinical significance[J]. Cancer Biotherapy & Radiopharmaceuticals,2018,33(9):373-379.
[13]	Shang S,Wang J,Chen S,et al. Exosomal miRNA-1231 derived from bone marrow mesenchymal stem cells inhibits the activity of pancreatic cancer[J]. Cancer Medicine,2019,8(18):7728-7740. doi: 10.1002/cam4.2633
[14]	邓思远,贺德,马广念,等. 微小RNA-490-3p对人胰腺癌的增殖,迁移,侵袭,凋亡的影响[J]. 中华实验外科杂志,2020,37(4):673-675. doi: 10.3760/cma.j.cn421213-20190715-01002
[15]	Ou Y,He J,Liu Y. MiR-490-3p inhibits autophagy via targeting ATG7 in hepatocellular carcinoma[J]. IUBMB Life,2018,70(6):468-478. doi: 10.1002/iub.1715
[16]	Fan H,Zhang Y S. miR-490-3p modulates the progression of prostate cancer through regulating histone deacetylase 2[J]. European Review for Medical and Pharmacological Sciences,2019,23(2):539-546.
[17]	Liu X,He B,Xu T,et al. MiR-490-3p functions as a tumor suppressor by inhibiting oncogene VDAC1 expression in colorectal cancer[J]. Journal of Cancer,2018,9(7):1218-1230. doi: 10.7150/jca.23662
[18]	Zhang F,Wu A,Wang Y,et al. miR-490-3p functions as a tumor suppressor in glioma by inhibiting high-mobility group AT-hook 2 expression[J]. Experimental and Therapeutic Medicine,2019,18(1):664-670.
[19]	De Craene B,Berx G. Regulatory networks defining EMT during cancer initiation and progression[J]. Nature Reviews Cancer,2013,13(2):97-110. doi: 10.1038/nrc3447
[20]	邹晨. Prrx1基因在胰腺癌EMT中的作用及机制研究[D], 南京: 南京医科大学博士学位论文, 2016.
[21]	朱亮. RGC-32在胰腺癌EMT中的作用及机制研究[D]; 武汉: 华中科技大学博士学位论文, 2012.
[22]	邵珊,秦涛,钱伟琨,等. Hedgehog通路通过非配体依赖途径调控缺氧诱导的胰腺癌EMT及侵袭过程[J]. 西安交通大学学报(医学版),2020,41(3):347-355.
[23]	Krebs A M,Mitschke J,Lasierra Losada M,et al. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer[J]. Nature Cell Biology,2017,19(5):518-529. doi: 10.1038/ncb3513
[24]	Fusco A,Fedele M. Roles of HMGA proteins in cancer[J]. Nature Reviews Cancer,2007,7(12):899-910. doi: 10.1038/nrc2271
[25]	Watanabe S,Ueda Y,Akaboshi S,et al. HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells[J]. The American Journal of Pathology,2009,174(3):854-868. doi: 10.2353/ajpath.2009.080523
[26]	Zhang S,Mo Q,Wang X. Oncological role of HMGA2 (Review)[J]. International Journal of Oncology,2019,55(4):775-788.
[27]	Hawsawi O,Henderson V,Burton L J,et al. High mobility group A2 (HMGA2) promotes EMT via MAPK pathway in prostate cancer[J]. Biochemical and Biophysical Research Communications,2018,504(1):196-202. doi: 10.1016/j.bbrc.2018.08.155
[28]	Dong J,Wang R,Ren G,et al. HMGA2-FOXL2 axis regulates metastases and epithelial-to-mesenchymal transition of chemoresistant gastric cancer[J]. Clinical Cancer Research:an Official Journal of the American Association for Cancer Research,2017,23(13):3461-3473. doi: 10.1158/1078-0432.CCR-16-2180

Relative Articles(20)

Relative Articles

[1]	Peng LI, Renchao ZOU, Longao DAI, Songzhou FU, Dong WEI, Bo TANG. The Effect of HIF-1α on Invasion and Metastasis of Gallbladder Cancer by Regulating the Epithelial-Mesenchymal Transformation. Journal of Kunming Medical University, 2024, 45(5): 44-48. doi: 10.12259/j.issn.2095-610X.S20240507
[2]	Lei ZHU, Ruixue LI, Changlei BAO, Chenchen HUANG, Shuxin LIANG, Zhenlin ZHAO, Hong ZHU. Effect of MSC-exo，a New Cell Delivery Tool，on Gene Delivery and Proliferation of Pancreatic Cancer. Journal of Kunming Medical University, 2024, 45(2): 39-48. doi: 10.12259/j.issn.2095-610X.S20240206
[3]	Runlin FENG, Zongqi DENG, Mengyao WU, Yunna WANG, Yu WANG, Guilan LIU. GJB4 Gene Expression in Relation to Clinical and Pathological Features of Pancreatic Cancer Patients. Journal of Kunming Medical University, 2024, 45(8): 1-9.
[4]	Qian XU, Yumei CUI, Siming MA, Yunhong LIN, Yijing XIONG, Zijun SONG, Xudong LI. miR-148a-3p Targeting SMURF2 in Regulating Osteogenic Differentiation and Enamel Development during In Vitro Tooth Organogenesis. Journal of Kunming Medical University, 2023, 44(11): 16-21. doi: 10.12259/j.issn.2095-610X.S20231103
[5]	Sijia LIU, Yaying YANG, Chao PENG, Yamin LI. Application of Contrast-enhanced CT and MRI in Preoperative TNM Staging of Pancreatic Cancer. Journal of Kunming Medical University, 2023, 44(6): 107-112. doi: 10.12259/j.issn.2095-610X.S20230628
[6]	Li Fei Fei , Hao Jin Gang . . Journal of Kunming Medical University, 2020, 41(04): 69-73.
[7]	Shen Hong , Wang Xiu Yun , Xu Hui Qiong , Liu Xia . Analysis of Clinicopathological Features of 274 Cases of Pancreatic Cancer and Risk Factors Affecting Prognosis. Journal of Kunming Medical University, 2019, 40(03): 97-101.
[8]	Zhao Bin , Li Rui Qian , Zhang Guo Ying , Lei Yong Hong , Wang Qi Lin , Liu Zhi Min . Overexpression of miR-4328 Inhibits the Proliferation, Migration and Epithelial Mesenchymal Transition of Prostate Cancer Cells. Journal of Kunming Medical University, 2017, 38(11): 29-33.
[9]	Wang Chun Long , Han Dan , Wen Liang . Research Progress of Mesothelin in Tumor Diagnosis and Treatment. Journal of Kunming Medical University, 2017, 38(09): 134-139.
[10]	Yang Ke , Dan Zu Jian , Zhou Qiong Hua , Wang Jun Feng . Relationship between Soluble Cytokine Receptors, Matrix Metalloproteinases and Pancreatic Cancer. Journal of Kunming Medical University, 2017, 38(01): 99-102.
[11]	Cao Yong Mei , Lv Yi , Liu Yu Jing , Li Ying Chuan . The Effect of miR-200 and Their Targets ZEB1/2 on Epithelial-mesenchymal Transition(EMT) in Early Pulmonary Fibrosis Caused by Acute Lung Injury. Journal of Kunming Medical University, 2016, 37(12): 1-7.
[12]	Hu Zheng Xiong . Effect of TGF-β2 and geneX on the Proliferation and Osteogenic Differentiation of BrdU-labeled Bone Mesenchymal Stem Cells. Journal of Kunming Medical University,
[13]	Hou Feng Qiang . . Journal of Kunming Medical University,
[14]	Lei Xue Fen . . Journal of Kunming Medical University,
[15]	Zhang Wei . . Journal of Kunming Medical University,
[16]	Tai Wen Lin . . Journal of Kunming Medical University,
[17]	Xu Jun . . Journal of Kunming Medical University,
[18]	Liu Bo . . Journal of Kunming Medical University,
[19]	. Inducing Differentiation of Pig's Bone Mesenchymal Stem Cell(BMSC) to Urothelial Epithelia in Vitro. Journal of Kunming Medical University,
[20]	. Inhibition of Canonical Wnt Signaling Pathway in Pancreatic Cancer by Interfering CXCR4 in Vitro. Journal of Kunming Medical University,